Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NORDIC CLINIC ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Bankruptcy risk for industry   0.8% 0.8% 0.8% 0.8% 0.8% 0.8% 0.8% 0.8%   Bankruptcy risk   4.9% 12.3% 5.9% 3.7% 5.9% 11.1% 18.5% 18.5%   Credit score (0-100)   46 20 41 52 38 21 7 8   Credit rating   BBB BB BBB BBB BBB BB B B   Credit limit (kDKK)   0.0 -0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   827 422 797 1,534 817 821 0.0 0.0   EBITDA   1.2 -377 7.4 147 211 -230 0.0 0.0   EBIT   -21.7 -415 -29.9 132 211 -230 0.0 0.0   Pre-tax profit (PTP)   -7.8 -417.4 25.5 171.3 -5.4 -84.9 0.0 0.0   Net earnings   -75.8 -369.3 31.4 138.5 -79.4 -93.8 0.0 0.0   Pre-tax profit without non-rec. items   -7.8 -417 25.5 171 -5.4 -84.9 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   131 -239 543 681 602 208 44.2 44.2   Interest-bearing liabilities   207 717 679 584 0.0 0.0 0.0 0.0   Balance sheet total (assets)   736 789 1,479 1,845 1,156 510 44.2 44.2   Net Debt   -182 477 395 -154 -666 -151 -44.2 -44.2     See the entire balance sheet 1000.0 Volume  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   827 422 797 1,534 817 821 0.0 0.0   Gross profit growth   0.7% -48.9% 88.6% 92.5% -46.7% 0.5% -100.0% 0.0%   Employees   2 2 2 2 2 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 50.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   736 789 1,479 1,845 1,156 510 44 44   Balance sheet change%   122.3% 7.1% 87.6% 24.7% -37.3% -55.9% -91.3% 0.0%   Added value   1.2 -377.0 7.4 147.2 226.7 -230.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   68 -75 -74 -31 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 -3.0 1.0 2.0 -1.0 0.0 0.0   1000.0 Profitability  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -2.6% -98.1% -3.8% 8.6% 25.9% -28.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -1.5% -44.4% -5.2% 10.4% 0.8% -9.1% 0.0% 0.0%   ROI %   -2.8% -74.3% 3.3% 13.8% 1.2% -18.6% 0.0% 0.0%   ROE %   -44.9% -80.3% 4.7% 22.6% -12.4% -23.1% 0.0% 0.0%   1000.0 Solidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Equity ratio %   17.8% -23.2% 37.2% 36.9% 52.1% 40.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -14,756.5% -126.6% 5,348.1% -104.8% -315.6% 65.7% 0.0% 0.0%   Gearing %   158.7% -300.3% 125.1% 85.8% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 5.6% 0.9% 0.3% 5.8% 0.0% 0.0% 0.0%   1000.0 Liquidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Quick Ratio   1.0 0.7 1.5 1.6 2.0 1.0 0.0 0.0   Current Ratio   1.1 0.7 1.5 1.6 2.0 1.0 0.0 0.0   Cash and cash equivalent   388.8 239.1 283.7 738.6 666.4 151.4 0.0 0.0   1000.0 Capital use efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   40.2 -333.2 472.5 666.0 506.0 4.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   1 -189 4 74 113 -77 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   1 -189 4 74 106 -77 0 0   EBIT / employee   -11 -207 -15 66 106 -77 0 0   Net earnings / employee   -38 -185 16 69 -40 -31 0 0